文献速递中毒与环境急症

美国解毒剂成本上升:2010年至2015年成本比较

Rising cost of antidotes in the U.S.: cost comparison from 2010 to 2015.
PubMed 文献 · Clin Toxicol (Phila) · 2017-02-06
一句话结论2010至2015年美国33种解毒剂中15种批发价涨幅超50%,8种涨幅超1000美元,可能影响医院储备与中毒救治。

该研究从已发表指南中获取解毒剂及最低储备推荐,利用RED BOOK Online®识别2010年和2015年美国平均批发价(AWP),并用美国消费者价格指数对2010年AWP进行通胀调整,计算并比较每种解毒剂最低储备水平的成本。结果显示,33种评估的解毒剂中15种AWP涨幅超过50%,8种涨幅超过1000美元;仅4种AWP降幅超过10%,仅1种储备成本AWP降幅超过1000美元。作者认为过去5年的价格上涨可能进一步阻碍医院按推荐数量储备解毒剂,可能妨碍及时治疗并负面影响中毒结局,建议研究剂量取整、寄售和区域共享等策略以降低储备和使用成本。

要点

  • 2010至2015年,33种解毒剂中15种平均批发价涨幅超过50%,8种涨幅超过1000美元。
  • 仅4种解毒剂平均批发价降幅超过10%,仅1种储备成本平均批发价降幅超过1000美元。
  • 作者认为价格上涨可能进一步阻碍医院按推荐数量储备解毒剂,可能妨碍及时治疗并负面影响中毒结局。
  • 作者建议研究剂量取整、寄售和区域共享等策略以降低解毒剂储备和使用成本。

研究设计与关键结果

  • 研究比较2010年与2015年美国33种解毒剂平均批发价(AWP)及最低储备成本;33种中15种AWP涨幅超过50%,8种涨幅超过1000美元;仅4种AWP降幅超过10%,仅1种储备成本AWP降幅超过1000美元。

证据类型、等级与局限

  • 证据类型:成本比较研究;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为解毒剂价格上涨可能进一步阻碍医院按推荐数量储备解毒剂,可能妨碍及时治疗并负面影响中毒结局;作者建议研究剂量取整、寄售和区域共享等策略以降低解毒剂储备和使用成本。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

CONTEXT: Our poison control center observed a large increase in the cost of many antidotes over the past several years. The high cost of antidotes has previously been cited as a factor leading to inadequate antidote supply at some hospitals. Continued increases in the cost of antidotes may lead to further reductions in antidote supply and represent serious concerns. This research aims to quantify recent trends in the costs of antidotes in the U.S.

METHODS: Antidotes and minimum stocking recommendations were retrieved from published guidelines. RED BOOK Online® was used to identify the U.S. average wholesale price (AWP) of each antidote in 2010 and 2015. The AWP in 2010 was adjusted using the U.S. Consumer Price Index to adjust for inflation. The cost of minimum stocking levels for each antidote was calculated and compared between the year 2010 and 2015.

RESULTS: The cost of stocking many antidotes demonstrated a large increase in AWP from 2010 to 2015. Of the antidotes evaluated, 15 out of 33 had greater than 50% increase in AWP and 8 out of 33 had greater than $1000 increase in AWP. Only four antidotes demonstrated decreases in AWP greater than 10% and only one antidote had its cost of stocking decrease in AWP by more than $1000.

DISCUSSION: The price increase over the last 5 years may further hinder the willingness of hospitals to stock recommended antidotes at adequate quantities. This may impede timely treatment of patients, and negatively impact poisoning outcomes.

CONCLUSIONS: The price of many antidotes substantially increased in the United States from 2010 to 2015. Strategies should be investigated to help decrease the cost associated with stocking and use of antidotes, including dose rounding, consignment, and regional sharing.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Heindel GA, Trella JD, Osterhoudt KC, et al. Rising cost of antidotes in the U.S.: cost comparison from 2010 to 2015. Clin Toxicol (Phila). 2017. PMID: 28165800. doi:10.1080/15563650.2017.1286014

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。